The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer

European Journal of Cancer

Volumn 48, Issue 8, 2012, Pages 1235-1243

  Hong, Sung Pil ^a   Min, Byung So ^a   Kim, Tae Il ^a   Cheon, Jae Hee ^a   Kim, Nam Kyu ^a   Kim, Hoguen ^a   Kim, Won Ho ^a  

^a Yonsei University   (South Korea)

Author keywords

Colon cancer; Microsatellite instability; Predictor; Prognosis; Rectal cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL;

ADULT; AGED; CANCER STAGING; COLON CANCER; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; REVIEW;

ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84860471420     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.10.005     Document Type: Article

References (32)

1. K. Jung, S. Park, and H. Kong Cancer statistics in Korea: incidence, mortality and survival in 2006-2007 J Korean Med Sci 25 2010 1113 1121
2. C.G. Moertel, T.R. Fleming, and J.S. Macdonald Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma N Engl J Med 322 1990 352 358
3. T. Andr, C. Boni, and L. Mounedji-Boudiaf Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2004 2343 2351
4. J.B. O'Connell, M.A. Maggard, and C.Y. Ko Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging J Natl Cancer Inst 96 2004 1420 1425
5. C.M. Ribic, D.J. Sargent, and M.J. Moore Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N Engl J Med 349 2003 247 257
6. S.N. Thibodeau, G. Bren, and D. Schaid Microsatellite instability in cancer of the proximal colon Science 260 1993 816 819
7. W.S. Samowitz, H. Albertsen, and J. Herrick Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer Gastroenterology 129 2005 837 845
8. K. Nosho, N. Irahara, and K. Shima Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample PLoS ONE 3 2008 e3698
9. A. de la Chapelle The incidence of Lynch syndrome Familial Cancer 4 2005 233 237
10. Y. Ionov, M.A. Peinado, S. Malkhosyan, D. Shibata, and M. Perucho Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis Nature 363 1993 558 561
11. H. Kim, J. Jen, B. Vogelstein, and S.R. Hamilton Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences Am J Pathol 145 1994 148 156
12. K.C. Halling, A.J. French, and S.K. McDonnell Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers J Natl Cancer Inst 91 1999 1295 1303
13. S. Popat, R. Hubner, and R.S. Houlston Systematic review of microsatellite instability and colorectal cancer prognosis J Clin Oncol 23 2005 609 618
14. G.P. Kim, L.H. Colangelo, and H.S. Wieand Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study J Clin Oncol 25 2007 767 772
15. A. Hemminki, J.P. Mecklin, H. Jrvinen, L.A. Aaltonen, and H. Joensuu Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy Gastroenterology 119 2000 921 928
16. H. Elsaleh, D. Joseph, and F. Grieu Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer Lancet 355 2000 1745 1750
17. A. de la Chapelle, and H. Hampel Clinical relevance of microsatellite instability in colorectal cancer J Clin Oncol 28 2010 3380 3387
18. W.S. Samowitz, K. Curtin, and R.K. Wolff Microsatellite instability and survival in rectal cancer Cancer Causes Control 20 2009 1763 1768
19. C.R. Boland, S.N. Thibodeau, and S.R. Hamilton A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer Cancer Res 58 1998 5248 5257
20. J.L. Tsao, Y. Yatabe, and R. Salovaara Genetic reconstruction of individual colorectal tumor histories Proc Natl Acad Sci USA 97 2000 1236 1241
21. M. Charara, T.B. Edmonston, and S. Burkholder Microsatellite status and cell cycle associated markers in rectal cancer patients undergoing a combined regimen of 5-FU and CPT-11 chemotherapy and radiotherapy Anticancer Res 24 2004 3161 3167
22. M. Colombino, A. Cossu, and A. Manca Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma Ann Oncol 13 2002 1447 1453
23. M. Nilbert, M. Planck, E. Fernebro, A. Borg, and A. Johnson Microsatellite instability is rare in rectal carcinomas and signifies hereditary cancer Eur J Cancer 35 1999 942 945
24. C. Guastadisegni, M. Colafranceschi, L. Ottini, and E. Dogliotti Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data Eur J Cancer 46 2010 2788 2798
25. W. Meng, X. Sun, and C. Tian Microsatellite instability did not predict individual survival in sporadic stage II and III rectal cancer patients Oncology 72 2007 82 88
26. D.G. Haller Defining the optimal therapy for rectal cancer J Natl Cancer Inst 92 2000 361 362
27. D.J. Sargent, S. Marsoni, and G. Monges Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer J Clin Oncol 28 2010 3219 3226
28. J.M. Carethers, D.P. Chauhan, and D. Fink Mismatch repair proficiency and in vitro response to 5-fluorouracil Gastroenterology 117 1999 123 131
29. A. Tajima, M.T. Hess, B.L. Cabrera, R.D. Kolodner, and J.M. Carethers The mismatch repair complex hMutS alpha recognizes 5-fluorouracil-modified DNA: implications for chemosensitivity and resistance Gastroenterology 127 2004 1678 1684
30. M.M. Bertagnolli, D. Niedzwiecki, and C.C. Compton Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803 J Clin Oncol 27 2009 1814 1821
31. S. Ogino, K. Nosho, and G.J. Kirkner CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer Gut 58 2009 90 96
32. A.J. French, D.J. Sargent, and L.J. Burgart Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer Clin Cancer Res 14 2008 3408 3415